Healthcare Services

Acute Kidney Injury Market Global Report 2026 Market Growth Expected to Reach $7.77 Billion by 2030 with 6.3% CAGR

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Acute Kidney Injury Market Over The Period 2026–2030?

The acute kidney injury market size has demonstrated significant growth recently. Projections indicate a rise from $5.72 billion in 2025 to $6.09 billion by 2026, at a compound annual growth rate (CAGR) of 6.5%. The historical expansion can be attributed to factors such as limited access to advanced renal care, an increasing prevalence of comorbidities like diabetes and hypertension, developing hospital infrastructure, the adoption of conventional dialysis techniques, and growing awareness of AKI complications.

The acute kidney injury market is projected to experience substantial growth over the coming years. By 2030, this market is anticipated to reach a valuation of $7.78 billion, expanding at a compound annual growth rate (CAGR) of 6.3%. This projected growth during the forecast period is primarily driven by advancements in renal replacement therapies, the creation of novel nephroprotective medications, the increasing number of ambulatory surgical centers, the growing application of biomarkers for early detection, and the incorporation of AI-based monitoring systems into renal care. Key trends expected within this period involve the greater uptake of dialysis and drug treatments, a global rise in the occurrence of acute kidney injury, an intensified focus on early diagnosis and biomarker development, the expansion of applications for urinary implants, and the adoption of minimally invasive techniques for managing AKI.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21079&type=smp

What Drivers Are Expected To Influence The Acute Kidney Injury Market During The Forecast Period?

The rising incidence of diabetes is anticipated to fuel the expansion of the acute kidney injury market. Diabetes is a collection of metabolic disorders marked by elevated blood glucose levels, resulting from either insufficient insulin production by the body or inadequate cellular response to insulin. This increasing prevalence stems from factors like growing obesity rates, unhealthy dietary habits, inactive lifestyles, an aging demographic, and improved detection and diagnostic methods. Acute kidney injury initiates metabolic and inflammatory shifts that can affect insulin resistance and glucose balance, pointing to an intricate relationship that could influence the progression and management of diabetes. For example, data from March 2024, provided by the UK’s Office for Health Improvement & Disparities, showed that from March 2022 to March 2023, the proportion of individuals with type 1 diabetes undergoing all eight recommended care processes grew by 22%, and for type 2 diabetes, it increased by 21%. Concurrently, the percentage reaching target HbA1c levels climbed to 37.9%, which was the highest figure ever recorded by the National Diabetes Audit (NDA). Consequently, the expanding occurrence of diabetes is propelling the growth of the acute kidney injury market.

How Is The Acute Kidney Injury Market Divided Into Its Major Segments?

The acute kidney injury market covered in this report is segmented –

1) By Injury: Pre-Renal Kidney Injury, Post-Renal Kidney Injury, Intrinsic Kidney Injury

2) By Treatment Type: Renal Replacement Therapy (RRT), Pharmacological Management, Supportive and Conservative Management, Obstruction-Relief Interventions

3) By End User: Hospitals, Dialysis Centers, Specialty Clinics, Other End Users

Subsegments:

1) By Pre-Renal Kidney Injury: Hypovolemia, Heart Failure-Related Injury, Sepsis-Induced Injury, Renal Artery Stenosis, Hepatorenal Syndrome

2) By Post-Renal Kidney Injury: Ureteral Obstruction, Bladder Outlet Obstruction, Prostate Enlargement (Benign Prostatic Hyperplasia), Kidney Stones, Tumors Affecting Urinary Tract

3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN), Acute Interstitial Nephritis (AIN), Glomerulonephritis, Vasculitis, Rhabdomyolysis-Induced Injury

How Are Trends Transforming The Acute Kidney Injury Market Landscape?

Leading companies in the acute kidney injury (AKI) market are concentrating on securing regulatory approvals to broaden their product offerings and provide innovative treatment options. Regulatory approvals represent the official authorization granted by governing bodies, such as the FDA or EMA, enabling a product to be sold and marketed once it meets established safety, efficacy, and quality criteria. As an illustration, in December 2023, Mission Therapeutics Ltd., a biotechnology firm based in the UK, obtained FDA clearance to commence a Phase II clinical trial for its primary compound, MTX652, specifically for acute kidney injury (AKI) in individuals facing high risks following cardiac surgery. This compound is designed to target crucial pathways involved in kidney injury and its repair process, with the goal of reducing inflammation, preventing further harm to the kidneys, and promoting recuperation. A distinctive aspect of this trial is its emphasis on leveraging novel therapeutic approaches to address the underlying molecular causes of AKI, which could potentially deliver more effective treatment alternatives compared to existing interventions. The Phase II trial will evaluate the safety, effectiveness, and pharmacokinetics of MTX652, gathering essential data that could support its broader clinical adoption and eventual approval.

Who Are The Prominent Organizations Shaping The Acute Kidney Injury Market?

Major companies operating in the acute kidney injury market are Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co. Ltd., Asahi Kasei Medical Co. Ltd., Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Quark Pharmaceuticals Inc., Kringle Pharma Inc., Aptabio Therapeutics Inc., AM-Pharma B.V., Arch Biopartners Inc., Guard Therapeutics International AB

Read the full acute kidney injury market report here:

https://www.thebusinessresearchcompany.com/report/acute-kidney-injury-global-market-report

Which Region Is Forecast To Lead The Acute Kidney Injury Market In Terms Of Market Size?

North America was the largest region in the acute kidney injury market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute kidney injury market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Acute Kidney Injury Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21079&type=smp

Browse Through More Reports Similar to the Global Acute Kidney Injury Market 2026, By The Business Research Company

kidney dialysis global market report

https://www.thebusinessresearchcompany.com/report/kidney-dialysis-global-market-report

acute spinal cord injury global market report

https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

rare kidney diseases global market report

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795